ACQUIRED METHAEMOGLOBINAEMIA

ACQUIRED METHAEMOGLOBINAEMIA was reported 44 times

ACQUIRED METHAEMOGLOBINAEMIA is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Sulfone [EPC] 5 0.0005
1 alpha-1 Adrenergic Agonist [EPC] 2 0.0005
2 Antimalarial [EPC] 1 0.0001
3 Antiprotozoal [EPC] 1 0.0001
4 Stimulant Laxative [EPC] 1 0.0001
5 Ester Local Anesthetic [EPC] 2 0.0000
6 Non-Standardized Chemical Allergen [EPC] 2 0.0000
7 Polyene Antifungal [EPC] 1 0.0000
8 Catecholamine [EPC] 2 0.0000
9 General Anesthetic [EPC] 1 0.0000
10 Amide Local Anesthetic [EPC] 2 0.0000
11 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
12 Antiarrhythmic [EPC] 2 0.0000
13 Antidote [EPC] 1 0.0000
14 Glycopeptide Antibacterial [EPC] 1 0.0000
15 Azole Antifungal [EPC] 2 0.0000
16 Xanthine Oxidase Inhibitor [EPC] 2 0.0000
17 Nitrate Vasodilator [EPC] 1 0.0000
18 Opioid Agonist [EPC] 3 0.0000
19 Loop Diuretic [EPC] 5 0.0000
20 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1 0.0000
21 5-alpha Reductase Inhibitor [EPC] 1 0.0000
22 Antirheumatic Agent [EPC] 1 0.0000
23 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1 0.0000
24 Anti-epileptic Agent [EPC] 2 0.0000
25 Sulfonylurea [EPC] 1 0.0000
26 Fluoroquinolone Antibacterial [EPC] 1 0.0000
27 Osmotic Laxative [EPC] 2 0.0000
28 Insulin Analog [EPC] 3 0.0000
29 Benzodiazepine [EPC] 4 0.0000
30 Thiazide Diuretic [EPC] 1 0.0000
31 Nonsteroidal Anti-inflammatory Drug [EPC] 6 0.0000
32 Kinase Inhibitor [EPC] 2 0.0000
33 Platelet Aggregation Inhibitor [EPC] 2 0.0000
34 HMG-CoA Reductase Inhibitor [EPC] 1 0.0000
35 Atypical Antipsychotic [EPC] 1 0.0000
36 Proton Pump Inhibitor [EPC] 1 0.0000
37 Corticosteroid [EPC] 2 0.0000